There are 16 resources available
Welcome and introduction
Presenter: Volkmar Mueller
Session: Medscape Global Oncology - Real-world HER2-positive early breast cancer: Optimising curative intent therapy
Resources:
Webcast
Optimizing HER2+ early breast cancer management: Where are we today?
Presenter: Volkmar Mueller
Session: Medscape Global Oncology - Real-world HER2-positive early breast cancer: Optimising curative intent therapy
Resources:
Webcast
Living with HER2: Understanding the road to survivorship
Presenter: Lesley Fallowfield
Session: Medscape Global Oncology - Real-world HER2-positive early breast cancer: Optimising curative intent therapy
Resources:
Webcast
Addressing disparities between clinical trials and clinical practice: From phase III to real-world setting
Presenter: Qiang Liu
Session: Medscape Global Oncology - Real-world HER2-positive early breast cancer: Optimising curative intent therapy
Resources:
Webcast
Navigating critical decision points in care pathways: Exploring best practices across borders
Presenter: Volkmar Mueller
Session: Medscape Global Oncology - Real-world HER2-positive early breast cancer: Optimising curative intent therapy
Resources:
Webcast
Q&A session and concluding remarks
Presenter: Volkmar Mueller
Session: Medscape Global Oncology - Real-world HER2-positive early breast cancer: Optimising curative intent therapy
Resources:
Webcast
Co-Chairman opening: Overview of the ESMO BC living guidelines in ER+/HER2- metastatic breast cancer setting
Presenter: Alessandra Gennari
Session: Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>−</b> advanced breast cancer
Resources:
Webcast
The current and future treatment landscape for ER+/HER2- metastatic breast cancer setting
Presenter: Valentina Guarneri
Session: Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>−</b> advanced breast cancer
Resources:
Webcast
Emerging biomarkers in breast cancer: Implementing liquid biopsy ESR1 mutation testing
Presenter: Volkmar Mueller
Session: Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>−</b> advanced breast cancer
Resources:
Webcast
Clinical experience and takeaways
Presenter: Alessandra Gennari
Session: Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>−</b> advanced breast cancer
Resources:
Webcast